Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023)
Neuroone Medical Technologies (NMTC) reported Change in Acquisitions & Divestments of $1.0 million for Q2 2023, down 50.0% quarter-over-quarter from $2.0 million in Q1 2023.
Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023) Analysis & Trends
Neuroone Medical Technologies has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $1.0 million in Q2 2023.
- For the quarter ending Q2 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2023 stood at $4.5 million (changed N/A YoY), and the FY2023 full-year result was $4.5 million, up 800.0% from the prior year.
- Change in Acquisitions & Divestments for Q2 2023 stood at $1.0 million, down from $2.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $2.0 million in Q1 2023, with the low at $1.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 27.15 Mn | 24.35 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |